Filter
213
Filtered Results: 213
Text search:
Guo
B.
Featured
Recommendations
16
New Publications
14
Language
Document type
Guidelines
67
Studies & Reports
64
No document type
48
Manuals
14
Fact sheets
13
Training Material
3
Situation Updates
2
Strategic & Response Plan
2
Countries / Regions
Russia
17
Global
13
Brazil
11
Germany
6
India
5
Peru
4
Latin America and the Carribbean
4
Middle East and North Africa
4
Western and Central Europe
4
Spain
4
Syria
3
Eastern Europe and Central Asia
3
France
3
Vietnam
3
Kenya
2
Ghana
2
Sierra Leone
2
Nigeria
2
Guinea
2
Mozambique
2
Asia
2
Congo, Democratic Republic of
2
West and Central Africa
2
Paraguay
2
Portugal
2
Eastern Europe
2
Angola
2
Ecuador
2
Nepal
1
Switzerland
1
Colombia
1
Ukraine
1
Turkey
1
Chile
1
Cameroon
1
Singapore
1
Laos
1
Burkina Faso
1
Austria
1
Italy
1
Africa
1
Cambodia
1
South–East Asia Region
1
United Kingdom
1
Bolivia
1
Bangladesh
1
South Africa
1
Uganda
1
Sudan
1
Yemen
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
75
Clinical Guidelines
14
Public Health
11
Capacity Building
3
Women & Child Health
3
Key Resources
3
Pharmacy & Technologies
3
Toolboxes
COVID-19
100
Planetary Health
23
Mental Health
20
NCDs
13
HIV
9
Disability
7
Ebola
4
Caregiver
4
Rapid Response
3
TB
3
NTDs
3
Pharmacy
2
Global Health Education
2
Specific Hazards
1
Cholera
1
Health Financing Toolbox
1
Conflict
1
AMR
1
MOH clinical practice guidelines
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag...
People with asthma (PWA) generally are considered at higher risk from respiratory infections, as is seen annually with influenza. At the outset of the COVID-19 pandemic, PWA were widely assumed to be at increased risk from COVID-19. However, as data emerged throughout 2020, the association between a...
In order to meet changing global population needs and consumer expectations, healthcare systems worldwide are under transformation and face restructuring. As systems adapt and shift their emphasis in response to the disparate requests for healthcare services, oppor-tunities emerge for nurses, especi...
16.7.2021
Note d’information scientifique, 17 juin 2021
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C...
La presente publicación describe la literatura científica revisada sobre las intervenciones farmacológicas para el tratamiento de la enfermedad por el coronavirus 2019. El Ministerio de Salud solicitó la revisión de la evidencia disponible para nueve intervenciones terapéuticas frente a COVID-...
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac...
La presente publicación describe la evidencia científica disponible sobre la efectividad del uso de mascarillas o respiradores en la prevención y control de infecciones respiratorias virales incluido COVID-19 a nivel comunitario y hospitalario. Se identificaron 778 estudios publicados hasta abril...
Uso de doxiciclina para prevenção e tratamento de pacientes com Covid-19
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
